## **Core Concept**
The treatment of medullary thyroid carcinoma (MTC) primarily involves surgical intervention, as it is a type of thyroid cancer that originates from the parafollicular cells (also known as C cells) of the thyroid gland. These cells produce calcitonin, and elevated levels of this hormone can be a marker for the disease. MTC can occur sporadically or as part of multiple endocrine neoplasia (MEN) syndromes.

## **Why the Correct Answer is Right**
The correct approach to treating medullary thyroid carcinoma often involves **surgery**. The primary surgical treatment is a **total thyroidectomy**, which may be accompanied by **central lymph node dissection** depending on the extent of the disease and the patient's risk factors. This surgical approach aims to remove the tumor completely and prevent recurrence. For patients with familial MTC or MEN 2, prophylactic thyroidectomy is considered early in life due to the high risk of developing MTC.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, treatments that are not primarily surgical, such as radioactive iodine therapy, are not the mainstay for MTC because MTC cells do not take up iodine.
- **Option B:** This option is also not provided, but treatments like chemotherapy or targeted therapy might be considered in advanced cases, not as a first-line treatment.
- **Option C:** Similarly, without the specific details, if an option suggests a non-surgical primary approach, it would be incorrect for the initial management of MTC.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **medullary thyroid carcinoma does not respond to radioactive iodine ablation** because the cells do not take up iodine. Therefore, surgical removal is the mainstay of treatment. Additionally, **screening for RET gene mutations** is crucial in familial cases and MEN syndromes to guide prophylactic surgery.

## **Correct Answer:** .